Literature DB >> 32325185

STAT signaling in polycystic kidney disease.

Sebastian Strubl1, Jacob A Torres2, Alison K Spindt2, Hannah Pellegrini2, Max C Liebau3, Thomas Weimbs4.   

Abstract

The most common form of polycystic kidney disease (PKD) in humans is caused by mutations in the PKD1 gene coding for polycystin1 (PC1). Among the many identified or proposed functions of PC1 is its ability to regulate the activity of transcription factors of the STAT family. Most STAT proteins that have been investigated were found to be aberrantly activated in kidneys in PKD, and some have been shown to be drivers of disease progression. In this review, we focus on the role of signal transducer and activator of transcription (STAT) signaling pathways in various renal cell types in healthy kidneys as compared to polycystic kidneys, on the mechanisms of STAT regulation by PC1 and other factors, and on the possibility to target STAT signaling for PKD therapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32325185      PMCID: PMC7269822          DOI: 10.1016/j.cellsig.2020.109639

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  223 in total

1.  Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease.

Authors:  J Morgan Knight; Pijus Mandal; Pietro Morlacchi; Garbo Mak; Evan Li; Matthew Madison; Cameron Landers; Brandon Saxton; Ed Felix; Brian Gilbert; Joel Sederstrom; Atul Varadhachary; Melissa M Singh; Dev Chatterjee; David B Corry; John S McMurray
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

Review 2.  Regulation of cytokine signaling pathways by PIAS proteins.

Authors:  Ke Shuai
Journal:  Cell Res       Date:  2006-02       Impact factor: 25.617

3.  Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.

Authors:  Onkar P Kulkarni; Ingo Hartter; Shrikant R Mulay; Jan Hagemann; Murthy N Darisipudi; Santhosh Kumar Vr; Simone Romoli; Dana Thomasova; Mi Ryu; Sebastian Kobold; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

4.  Structural basis of substrate methylation and inhibition of SMYD2.

Authors:  Andrew D Ferguson; Nicholas A Larsen; Tina Howard; Hannah Pollard; Isabelle Green; Christie Grande; Tony Cheung; Renee Garcia-Arenas; Scott Cowen; Jiaquan Wu; Robert Godin; Huawei Chen; Nicholas Keen
Journal:  Structure       Date:  2011-07-21       Impact factor: 5.006

5.  Are Cyst-Associated Macrophages in Polycystic Kidney Disease the Equivalent to TAMs in Cancer?

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2018-09-12       Impact factor: 10.121

6.  PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2.

Authors:  Anil Kumar Bhunia; Klaus Piontek; Alessandra Boletta; Lijuan Liu; Feng Qian; Pei Ning Xu; F Joseph Germino; Gregory G Germino
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

7.  Angiogenesis in autosomal-dominant polycystic kidney disease.

Authors:  E Bello-Reuss; K Holubec; S Rajaraman
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

8.  Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases.

Authors:  P J Winyard; Q Bao; R C Hughes; A S Woolf
Journal:  J Am Soc Nephrol       Date:  1997-11       Impact factor: 10.121

9.  JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.

Authors:  A C Breggia; D M Wojchowski; J Himmelfarb
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

10.  Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease.

Authors:  Darren P Wallace; Corey White; Lyudmyla Savinkova; Emily Nivens; Gail A Reif; Cibele S Pinto; Archana Raman; Stephen C Parnell; Simon J Conway; Timothy A Fields
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

View more
  5 in total

1.  Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation.

Authors:  Julia Katharina Scholz; Andre Kraus; Dominik Lüder; Kathrin Skoczynski; Mario Schiffer; Steffen Grampp; Johannes Schödel; Bjoern Buchholz
Journal:  iScience       Date:  2022-05-05

Review 2.  A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers.

Authors:  Luis M Ruiz-Manriquez; Schoenstatt Janin Ledesma Pacheco; Daniel Medina-Gomez; Andrea G Uriostegui-Pena; Carolina Estrada-Meza; Anindya Bandyopadhyay; Surajit Pathak; Antara Banerjee; Samik Chakraborty; Aashish Srivastava; Sujay Paul
Journal:  Genes (Basel)       Date:  2022-01-22       Impact factor: 4.096

3.  Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression.

Authors:  Masaw Akbari; Jonathan D West; Nicholas Doerr; Kevin R Kipp; Neda Marhamati; Sabrina Vuong; Yidi Wang; Markus M Rinschen; Jeffrey J Talbot; Oliver Wessely; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

Review 4.  Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling.

Authors:  Xia Zhou; Vicente E Torres
Journal:  Front Mol Biosci       Date:  2022-09-02

5.  The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation.

Authors:  Claudia Dafinger; Amrei M Mandel; Alina Braun; Heike Göbel; Kathrin Burgmaier; Laura Massella; Antonio Mastrangelo; Jörg Dötsch; Thomas Benzing; Thomas Weimbs; Bernhard Schermer; Max C Liebau
Journal:  J Cell Mol Med       Date:  2020-10-28       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.